Vemer P - Search Results

1

Research Costs Investigated: A Study Into the Budgets of Dutch Publicly Funded Drug-Related Research.

van Asselt T, Ramaekers B, Corro Ramos I, Joore M, Al M, Lesman-Leegte I, Postma M, Vemer P, Feenstra T. van Asselt T, et al. Among authors: vemer p. Pharmacoeconomics. 2018 Jan;36(1):105-113. doi: 10.1007/s40273-017-0572-7. Pharmacoeconomics. 2018. PMID: 28933003 Free PMC article.

2

AdViSHE: A Validation-Assessment Tool of Health-Economic Models for Decision Makers and Model Users.

Vemer P, Corro Ramos I, van Voorn GA, Al MJ, Feenstra TL. Vemer P, et al. Pharmacoeconomics. 2016 Apr;34(4):349-61. doi: 10.1007/s40273-015-0327-2. Pharmacoeconomics. 2016. PMID: 26660529 Free PMC article.

3

Advishe: a New Tool to Report Validation of Health-Economic Decision Models.

Vemer P, Corro Ramos I, Van Voorn G, Al MJ, Feenstra TL. Vemer P, et al. Value Health. 2014 Nov;17(7):A556-7. doi: 10.1016/j.jval.2014.08.1831. Epub 2014 Oct 26. Value Health. 2014. PMID: 27201828 Free article. No abstract available.

4

A choice that matters? Smulation study on the impact of direct meta-analysis methods on health economic outcomes.

Vemer P, Al MJ, Oppe M, Rutten-van Mölken MP. Vemer P, et al. Pharmacoeconomics. 2013 Aug;31(8):719-30. doi: 10.1007/s40273-013-0067-0. Pharmacoeconomics. 2013. PMID: 23736971

5

Improving model validation in health technology assessment: comments on guidelines of the ISPOR-SMDM modeling good research practices task force.

Vemer P, van Voom GA, Ramos IC, Krabbe PF, Al MJ, Feenstra TL. Vemer P, et al. Value Health. 2013 Sep-Oct;16(6):1106-7. doi: 10.1016/j.jval.2013.06.015. Value Health. 2013. PMID: 24041364 Free article. No abstract available.

6

Unremarked or Unperformed? Systematic Review on Reporting of Validation Efforts of Health Economic Decision Models in Seasonal Influenza and Early Breast Cancer.

de Boer PT, Frederix GW, Feenstra TL, Vemer P. de Boer PT, et al. Among authors: vemer p. Pharmacoeconomics. 2016 Sep;34(9):833-45. doi: 10.1007/s40273-016-0410-3. Pharmacoeconomics. 2016. PMID: 27129572 Free PMC article. Review.

7

An Economic Evaluation of Sacubitril/Valsartan for Heart Failure Patients in the Netherlands.

van der Pol S, Degener F, Postma MJ, Vemer P. van der Pol S, et al. Among authors: vemer p. Value Health. 2017 Mar;20(3):388-396. doi: 10.1016/j.jval.2016.10.015. Epub 2016 Dec 22. Value Health. 2017. PMID: 28292483 Free article.

8

A New Statistical Method to Determine the Degree of Validity of Health Economic Model Outcomes against Empirical Data.

Corro Ramos I, van Voorn GAK, Vemer P, Feenstra TL, Al MJ. Corro Ramos I, et al. Among authors: vemer p. Value Health. 2017 Sep;20(8):1041-1047. doi: 10.1016/j.jval.2017.04.016. Epub 2017 May 29. Value Health. 2017. PMID: 28964435 Free article.

9

A few years later. Update of the cost-effectiveness of infant pneumococcal vaccination in Dutch children.

Vemer P, Postma MJ. Vemer P, et al. Hum Vaccin Immunother. 2014;10(7):1841-9. doi: 10.4161/hv.29008. Hum Vaccin Immunother. 2014. PMID: 25424791 Free PMC article.

10

The Missing Stakeholder Group: Why Patients Should be Involved in Health Economic Modelling.

van Voorn GA, Vemer P, Hamerlijnck D, Ramos IC, Teunissen GJ, Al M, Feenstra TL. van Voorn GA, et al. Among authors: vemer p. Appl Health Econ Health Policy. 2016 Apr;14(2):129-33. doi: 10.1007/s40258-015-0200-7. Appl Health Econ Health Policy. 2016. PMID: 26385585 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters